{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:42:45Z","timestamp":1789843365352,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bioorg.2019.103216","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T01:58:29Z","timestamp":1566525509000},"page":"103216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl)thiophene-2-carboxamide analogs"],"prefix":"10.1016","volume":"92","author":[{"given":"Gulraiz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer Fawad","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bioorg.2019.103216_b0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy","volume":"264","author":"Manford","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.bioorg.2019.103216_b0010","doi-asserted-by":"crossref","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2019.103216_b0015","first-page":"61","article-title":"Epilepsy\u2013a comprehensive review","volume":"2","author":"Suruchi","year":"2013","journal-title":"Int. J. Pharm. Res. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103216_b0020","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bioorg.2019.103216_b0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.addr.2011.11.006","article-title":"Chemical properties of antiepileptic drugs (AEDs)","volume":"64","author":"Bialer","year":"2012","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103216_b0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3928\/00904481-20150203-10","article-title":"Antiepileptic drugs-a review","volume":"44","author":"Sankaraneni","year":"2015","journal-title":"Pediatr Ann."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103216_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13054-018-2066-1","article-title":"Antiepileptic drugs in critically ill patients","volume":"22","author":"Salia","year":"2018","journal-title":"Critic. Care"},{"key":"10.1016\/j.bioorg.2019.103216_b0040","series-title":"Drug Design Discovery in Alzheimer \u2018s Disease","first-page":"40","article-title":"Challenges in designing therapeutic agents treating Alzheimer \u2018s disease-form serendipity to rationality","author":"Rashid","year":"2014"},{"key":"10.1016\/j.bioorg.2019.103216_b0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2011.00251.x","article-title":"Seizures and epilepsy in Alzheimer's disease","volume":"18","author":"Friedman","year":"2012","journal-title":"CNS. Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103216_b0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/WAD.0000000000000134","article-title":"Epileptic seizures in alzheimer disease, a review","volume":"30","author":"Horv\u00e1th","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103216_b0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14737175.2017.1243469","article-title":"Treatment of epilepsy in patients with Alzheimer's disease","volume":"17","author":"Giorgi","year":"2017","journal-title":"Expert Rev. Neurother."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103216_b0060","first-page":"39578","article-title":"Alzheimers\u2019 disease and epilepsy: a literature review","volume":"4","author":"Raudino","year":"2017","journal-title":"Arch. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103216_b0065","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.bioorg.2019.103216_b0070","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/ijms18112311","article-title":"Diverse effects of an acetylcholinesterase inhibitor, donepezil, on hippocampal neuronal death after pilocarpine-induced seizure","volume":"18","author":"Jeong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103216_b0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bcpt.12275","article-title":"Adjuvant anticholinesterase therapy for the management of epilepsy-induced memory deficit: a critical pre-clinical study","volume":"115","author":"Mishra","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103216_b0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yebeh.2008.08.013","article-title":"Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats","volume":"14","author":"Mares","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103216_b0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/fcp.12090","article-title":"Memantine delayed N-methyl-D-aspartate -induced convulsions in neonatal rats","volume":"29","author":"Dhir","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103216_b0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.bioorg.2019.103216_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2404","article-title":"Antiepileptic drugs in Alzheimer\u2019s","volume":"44","author":"Feliciano","year":"2012","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103216_b0100","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2019.103216_b0105","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103216_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bioorg.2019.103216_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bioorg.2016.10.002","article-title":"Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors","volume":"69","author":"Ahmad","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bioorg.2018.10.035","article-title":"Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors","volume":"83","author":"Tanoli","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13065-018-0451-0","article-title":"Facile synthesis of N- (4-bromophenyl)-1- (3-bromothiophen-2-yl)methanimine derivatives via Suzuki cross-coupling reaction, their characterization and DFT studies","volume":"12","author":"Rizwan","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2019.103216_b0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13065-018-0404-7","article-title":"Palladium (0) catalyzed Suzuki cross-coupling reaction of 2, 5-dibromo-3-methylthiophene selectivity, characterization, DFT studies and their biological evaluations","volume":"12","author":"Rizwan","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.bioorg.2019.103216_b0135","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.3390\/molecules20035202","article-title":"Selective C-Arylation of 2, 5-Dibromo-3-hexylthiophene via Suzuki cross coupling reaction and their pharmacological aspects","volume":"20","author":"Ikram","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103216_b0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/molecules21080977","article-title":"Efficient double suzuki cross-coupling reactions of 2, 5-dibromo-3-hexylthiophene anti-tumor, haemolytic, anti-thrombolytic and biofilm inhibition studies","volume":"21","author":"Ikram","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.103216_b0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/17415993.2015.1020493","article-title":"Palladium (0) catalyzed Suzuki cross-coupling reactions of 2,4-dibromothiophene: selectivity, characterization and biological applications","volume":"36","author":"Rasheed","year":"2015","journal-title":"J. Sulfur Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejmech.2013.10.024","article-title":"Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors","volume":"70","author":"Asadipour","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0155","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14656566.2016.1168399","article-title":"Carbamazepine-related antiepileptic drugs for the treatment of epilepsy-a comparative review","volume":"17","author":"Gierbolini","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2019.103216_b0160","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1529\/biophysj.108.129601","article-title":"Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase X-ray versus molecular dynamics","volume":"95","author":"Xu","year":"2008","journal-title":"Biophys. J."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103216_b0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.bioorg.2019.103216_b0170","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0175","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-based search for new inhibitors of cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2019.103216_b0180","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1186\/s40064-016-2996-5","article-title":"Halogen-directed drug design for Alzheimer\u2019s disease: a combined density functional and molecular docking study","volume":"5","author":"Rahman","year":"2016","journal-title":"Springer Plus"},{"key":"10.1016\/j.bioorg.2019.103216_b0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature13293","article-title":"crystal structure of a human GABAA receptor","volume":"512","author":"Miller","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2019.103216_b0190","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/jm5007935","article-title":"Rational use of plasma protein and tissue binding data in drug design","volume":"57","author":"Liu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform. An Alzheimer\u2019s Disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Haibin","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2019.103216_b0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2010.06.034","article-title":"Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice","volume":"1351","author":"Abdallah","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2019.103216_b0205","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(96)01496-5","article-title":"L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice","volume":"753","author":"Kaputlu","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.bioorg.2019.103216_b0210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jnr.23500","article-title":"N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole induced convulsions and morphological changes in rat brain neurons","volume":"93","author":"Zaitsev","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bioorg.2019.103216_b0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eplepsyres.2012.11.006","article-title":"Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats","volume":"104","author":"Vilela","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bioorg.2019.103216_b0220","unstructured":"Molecular Operating Environment (MOE), 2016.08; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2018."},{"key":"10.1016\/j.bioorg.2019.103216_b0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bioorg.2018.05.026","article-title":"Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines","volume":"80","author":"Iftikhar","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103216_b0230","unstructured":"Dassault Syst\u00e8mes BIOVIA, Discovery Studio Modelling Environment, Release 4.5, San Diego: Dassault Systems, 2015."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819304420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819304420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:53:43Z","timestamp":1758614023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819304420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":46,"alternative-id":["S0045206819304420"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103216","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl)thiophene-2-carboxamide analogs","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103216"}}